Abstract
Modification of A ring of 10-deacetylbaccatin III to get novel rearranged taxoids is described. The modification is achieved via manoeuvering of the C-11 double bond of 10-deacetylbaccatin III.
Keywords: 10-deacetylbaccatin III, rearranged taxoids, Taxus baccata var, Wallichiana, m-chloroperbenzoic acid (m-CPBA)
Letters in Organic Chemistry
Title: Modification of Taxane A Ring via Manoeuvering of the C-11 Double Bond of 10-Deacetylbaccatin III to Get Novel Rearranged Taxoids
Volume: 5 Issue: 8
Author(s): Vaishali Chakraborty and Manobjyoti Bordoloi
Affiliation:
Keywords: 10-deacetylbaccatin III, rearranged taxoids, Taxus baccata var, Wallichiana, m-chloroperbenzoic acid (m-CPBA)
Abstract: Modification of A ring of 10-deacetylbaccatin III to get novel rearranged taxoids is described. The modification is achieved via manoeuvering of the C-11 double bond of 10-deacetylbaccatin III.
Export Options
About this article
Cite this article as:
Chakraborty Vaishali and Bordoloi Manobjyoti, Modification of Taxane A Ring via Manoeuvering of the C-11 Double Bond of 10-Deacetylbaccatin III to Get Novel Rearranged Taxoids, Letters in Organic Chemistry 2008; 5 (8) . https://dx.doi.org/10.2174/157017808786857543
DOI https://dx.doi.org/10.2174/157017808786857543 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ganoderma lucidum (Ling-zhi): The Impact of Chemistry on Biological Activity in Cancer
Current Bioactive Compounds Polymeric Nanomicelles of Soluplus® as a Strategy for Enhancing the Solubility, Bioavailability and Efficacy of Poorly Soluble Active Compounds
Current Nanomedicine Editorial from Guest Editor (DNA Methylation: A Target for Current and Future Therapies?)
Epigenetic Diagnosis & Therapy (Discontinued) Current Highlights About the Safety of Inorganic Nanomaterials in Healthcare
Current Medicinal Chemistry Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
Current Medicinal Chemistry Imaging Methods in Gene Therapy of Cancer
Current Gene Therapy Nanostructured Cubosomes as a Platform for Oral Drug Delivery
Current Pharmaceutical Biotechnology Radioligands for the Angiotensin II Subtype 1 (AT1) Receptor
Current Topics in Medicinal Chemistry Activatable Optical Probes for the Detection of Enzymes
Current Organic Synthesis Cry1A Proteins are Cytotoxic to HeLa but not to SiHa Cervical Cancer Cells
Current Pharmaceutical Biotechnology 2-Arylbenzothiazole as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry Quantization of Angiogenesis and Image Analysis
Current Angiogenesis (Discontinued) Peptides Targeting Estrogen Receptor Alpha-Potential Applications for Breast Cancer Treatment
Current Pharmaceutical Design In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha
Current Computer-Aided Drug Design Stressed to Death: Targeting Endoplasmic Reticulum Stress Response Induced Apoptosis in Gliomas
Current Pharmaceutical Design PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Current Medicinal Chemistry MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications
Current Molecular Medicine Development of Anti-Atherosclerosis Therapy Based on the Inflammatory and Proliferative Aspects of the Disease
Current Pharmaceutical Design Mechanisms of the Penetration of Blood-Borne Substances into the Brain
Current Neuropharmacology Folic Acid Conjugated Chitosan Nanoparticles for Tumor Targeting of Therapeutic and Imaging Agents
Pharmaceutical Nanotechnology